256 related articles for article (PubMed ID: 21283616)
1. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.
Anh DD; Lopez AL; Thiem VD; Grahek SL; Duong TN; Park JK; Kwon HJ; Favorov M; Hien NT; Clemens JD
PLoS Negl Trop Dis; 2011 Jan; 5(1):e1006. PubMed ID: 21283616
[TBL] [Abstract][Full Text] [Related]
2. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam.
Thiem VD; Deen JL; von Seidlein L; Canh DG; Anh DD; Park JK; Ali M; Danovaro-Holliday MC; Son ND; Hoa NT; Holmgren J; Clemens JD
Vaccine; 2006 May; 24(20):4297-303. PubMed ID: 16580760
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
5. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
Fakoya B; Sit B; Waldor MK
J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
[TBL] [Abstract][Full Text] [Related]
7. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
[TBL] [Abstract][Full Text] [Related]
9. The case for reactive mass oral cholera vaccinations.
Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
[TBL] [Abstract][Full Text] [Related]
10. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
Schwerdtle P; Onekon CK; Recoche K
Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
[TBL] [Abstract][Full Text] [Related]
11. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.
Lopez AL; Deen J; Azman AS; Luquero FJ; Kanungo S; Dutta S; von Seidlein L; Sack DA
Clin Infect Dis; 2018 Jun; 66(12):1960-1971. PubMed ID: 29177437
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.
Sur D; Kanungo S; Sah B; Manna B; Ali M; Paisley AM; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Han SH; Attridge S; Donner A; Ganguly NK; Bhattacharya SK; Nair GB; Clemens JD; Lopez AL
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1289. PubMed ID: 22028938
[TBL] [Abstract][Full Text] [Related]
15. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.
Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Muller V; Llosa AE; Uzzeni F; Luquero FJ; Ciglenecki I; Azman AS
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005652. PubMed ID: 28594891
[TBL] [Abstract][Full Text] [Related]
16. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
Anh DD; Canh DG; Lopez AL; Thiem VD; Long PT; Son NH; Deen J; von Seidlein L; Carbis R; Han SH; Shin SH; Attridge S; Holmgren J; Clemens J
Vaccine; 2007 Jan; 25(6):1149-55. PubMed ID: 17055622
[TBL] [Abstract][Full Text] [Related]
18. Improving immunization approaches to cholera.
Saha A; Rosewell A; Hayen A; MacIntyre CR; Qadri F
Expert Rev Vaccines; 2017 Mar; 16(3):235-248. PubMed ID: 27805467
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]